{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:14:37Z","timestamp":1780384477122,"version":"3.54.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.amjcard.2012.12.052","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T11:45:44Z","timestamp":1359546344000},"page":"1221-1229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Safety and Effect of Very Low Levels of Low-Density Lipoprotein Cholesterol on Cardiovascular Events"],"prefix":"10.1016","volume":"111","author":[{"given":"John C.","family":"LaRosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje R.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ransi","family":"Somaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.12.052_bib1","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1001\/jama.1987.03390160062027","article-title":"Cholesterol and mortality: 30 years of follow-up from the Framingham study","volume":"257","author":"Anderson","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.12.052_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib4","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib5","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.12.052_bib6","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Treating to new targets: I. Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib8","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jacc.2008.05.046","article-title":"Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis","volume":"52","author":"Giraldez","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/clp.11.4","article-title":"Intensifying statin therapy to maximize cardiovascular risk reduction: is 50 the new 70? Goals are getting old","volume":"6","author":"Ramjee","year":"2011","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0026-0495(83)90207-X","article-title":"Decline in the concentration of low-density lipoprotein-cholesterol in human fetal plasma near term","volume":"32","author":"Parker","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.amjcard.2012.12.052_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.amjcard.2012.12.052_bib12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-2275(20)36969-8","article-title":"Effect of dietary cholesterol on cholesterol synthesis in breast-fed and formula-fed infants","volume":"34","author":"Wong","year":"1993","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.amjcard.2012.12.052_bib13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1006\/pmed.1998.0376","article-title":"Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey","volume":"27","author":"Hickman","year":"1998","journal-title":"Prev Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.amjcard.2010.05.030","article-title":"30-Year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999\u20132006","volume":"106","author":"Cohen","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ajp.1083","article-title":"Effects of food availability on serum insulin and lipid\u00a0concentrations in free-ranging baboons","volume":"57","author":"Kemnitz","year":"2002","journal-title":"Am J Primatol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.108.816769","article-title":"Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States","volume":"119","author":"Ford","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.12.052_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(86)90597-0","article-title":"Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men","volume":"2","author":"Martin","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.ATV.0000012662.29622.00","article-title":"Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study","volume":"22","author":"Jaffer","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1753944710368206","article-title":"Lipid lowering goals: back to nature?","volume":"4","author":"Hochholzer","year":"2010","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.amjcard.2012.12.052_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s003940050005","article-title":"Dietary lean red meat and human evolution","volume":"39","author":"Mann","year":"2000","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.amjcard.2012.12.052_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1590\/S0066-782X2007000100006","article-title":"Vegetarian diet and cholesterol and triglycerides levels","volume":"88","author":"De Biase","year":"2007","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib22","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jacc.2004.03.046","article-title":"Optimal low-density lipoprotein is 50 to 70 mg\/dl: lower is better and physiologically normal","volume":"43","author":"O'Keefe","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib23","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJM199112123252405","article-title":"Changes in lipid and lipoprotein levels and body weight in Tarahumara Indians after consumption of an affluent diet","volume":"325","author":"McMurry","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib24","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3402\/ijch.v71i0.17342","article-title":"Metabolic profile in two physically active Inuit groups consuming either a western or a traditional Inuit diet","volume":"71","author":"Munch-Andersen","year":"2012","journal-title":"Int J Circumpolar Health"},{"key":"10.1016\/j.amjcard.2012.12.052_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/bmj.303.6797.276","article-title":"Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations","volume":"303","author":"Chen","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2012.12.052_bib26","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archinte.1981.00340090024008","article-title":"Lipoproteins, cardiovascular disease, and death: the Framingham study","volume":"141","author":"Gordon","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial","volume":"320","author":"Iso","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/bjc.1989.198","article-title":"Serum cholesterol and subsequent risk of cancer: results from the BUPA study","volume":"59","author":"Wald","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.amjcard.2012.12.052_bib31","first-page":"253","article-title":"Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies","volume":"2","author":"Law","year":"1991","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.amjcard.2012.12.052_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/bmj.308.6925.373","article-title":"Assessing possible hazards of reducing serum cholesterol","volume":"308","author":"Law","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2012.12.052_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(92)90182-G","article-title":"Low serum cholesterol, cancer and other noncardiovascular disorders","volume":"94","author":"Epstein","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2012.12.052_bib34","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1158\/1055-9965.EPI-08-1248","article-title":"Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer","volume":"18","author":"Ahn","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.amjcard.2012.12.052_bib35","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/annonc\/mdn736","article-title":"Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study","volume":"20","author":"Strasak","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib36","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.24668","article-title":"Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts","volume":"125","author":"Iso","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.amjcard.2012.12.052_bib37","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1158\/1055-9965.EPI-09-0472","article-title":"Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial","volume":"18","author":"Platz","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.amjcard.2012.12.052_bib38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0022-2275(20)42750-6","article-title":"Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys","volume":"31","author":"Ettinger","year":"1990","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.amjcard.2012.12.052_bib39","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0140-6736(85)92679-0","article-title":"Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia","volume":"2","author":"Vitols","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djj188","article-title":"Statin use and breast cancer: prospective results from the Women's Health Initiative","volume":"98","author":"Cauley","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.amjcard.2012.12.052_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.106.650176","article-title":"Statins and the risk of lung, breast, and colorectal cancer in the elderly","volume":"115","author":"Setoguchi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.12.052_bib42","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib43","doi-asserted-by":"crossref","first-page":"e29849","DOI":"10.1371\/journal.pone.0029849","article-title":"Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy","volume":"7","author":"Emberson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.amjcard.2012.12.052_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjmed.2007.12.011","article-title":"Statins and cancer risk","volume":"121","author":"Karp","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib45","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/cncr.25731","article-title":"Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use","volume":"117","author":"Samadder","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.amjcard.2012.12.052_bib46","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib47","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1212\/01.wnl.0000296277.63350.77","article-title":"Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study","volume":"70","author":"Goldstein","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2012.12.052_bib48","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2010.09.082","volume":"57","author":"Hsia","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib50","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.12.052_bib51","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacl.2010.02.009","article-title":"New mutations in APOB100 involved in familial hypobetalipoproteinemia","volume":"4","author":"Brusgaard","year":"2010","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/157016111794519354","article-title":"Hypocholesterolemia","volume":"9","author":"Moutzouri","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1665-2681(19)31564-9","article-title":"Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease","volume":"10","author":"Gutierrez-Cirlos","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0022-2275(20)39976-4","article-title":"Familial hypobetalipoproteinemia","volume":"34","author":"Linton","year":"1993","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.amjcard.2012.12.052_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-12-387025-4.00004-2","article-title":"Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum","volume":"54","author":"Tarugi","year":"2011","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.amjcard.2012.12.052_bib57","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.0000176191.64314.07","article-title":"Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia","volume":"25","author":"Sankatsing","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib58","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacl.2011.06.014","article-title":"A\u00a0novel mutation of apolipoprotein B in a French Canadian family with homozygous hypobetalipoproteinemia","volume":"5","author":"Gangloff","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib59","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0026-0495(97)90004-4","article-title":"Prospective 10-year evaluation of hypobetalipoproteinemia in a cohort of 772 firefighters and cross-sectional evaluation of hypocholesterolemia in 1,479 men in the National Health and Nutrition Examination Survey I","volume":"46","author":"Glueck","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.amjcard.2012.12.052_bib60","doi-asserted-by":"crossref","first-page":"50630","DOI":"10.1074\/jbc.M410077200","article-title":"Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver","volume":"279","author":"Park","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.amjcard.2012.12.052_bib61","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjcard.2012.12.052_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib63","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib64","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/ATVBAHA.109.194191","article-title":"PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia","volume":"29","author":"Cariou","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/ATVBAHA.110.220988","article-title":"Circulating proprotein convertase subtilisin\/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue","volume":"31","author":"Roubtsova","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-3-19","article-title":"Abetalipoproteinemia: two case reports and literature review","volume":"3","author":"Zamel","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.amjcard.2012.12.052_bib67","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib69","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjcard.2003.09.031","article-title":"Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?","volume":"93","author":"Waters","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib70","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2012.12.052_bib71","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Armitage","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.12.052_bib72","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.12.052_bib73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MCA.0b013e328337ad09","article-title":"Impact of the attainment of current recommended low-density lipoprotein cholesterol goal of less than 70 mg\/dl on clinical outcomes in very high-risk patients treated with drug-eluting stents","volume":"21","author":"Kim","year":"2010","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjcard.2012.12.052_bib74","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2007.03.102","article-title":"Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study)","volume":"100","author":"LaRosa","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib75","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","article-title":"Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy","volume":"46","author":"Wiviott","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib76","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.amjcard.2005.07.069","article-title":"Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoprotein<or=80 mg\/dl","volume":"96","author":"Tsai","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.12.052_bib77","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/CIRCULATIONAHA.107.694117","article-title":"Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival","volume":"116","author":"Leeper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.12.052_bib78","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jacc.2011.05.057","article-title":"Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol","volume":"58","author":"Lee","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912026550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912026550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:02:53Z","timestamp":1762077773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912026550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0002914912026550"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.12.052","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Effect of Very Low Levels of Low-Density Lipoprotein Cholesterol on Cardiovascular Events","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.12.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}